URGN UroGen Pharma Ltd. - Ordinary Shares
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$41,40
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$15,8652 haftanın en düşüğü
$50,8152 haftanın en yükseği
Piyasa Değeri (MRQ)
$2.02B
Gelir
$110M
rozetleriniz
52 Haftlık Aralık
$16–$51
Analist Derecelendirmesi
STRONG BUY
Fiyat Hedefi
$60
P/E
·
ROE
154.4%
Net Kâr Marjı
-51.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
URGN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$41.40
Piyasa Değeri (MRQ)
$2.02B
Gelir
$110M
ROE
154.4%
D/E Borç/Özsermaye (MRQ)
-1.4
52 Haftlık Aralık
$16–$51
URGN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$110M2016-12-31 → 2025-12-31
Serbest Nakit Akışı$-163M2018-12-31 → 2025-12-31
Net kar marjı-51.7%2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | URGN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| F/S (TTM) | 10.7 | · | · | · | |
| F/D (MRQ) | -15.3 | · | · | · | |
| EV / EBITDA (TTM) | -31.7 | · | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -12.7 | · | · | · | |
| Fiyat / Nakit Akışı (TTM) | -12.7 | · | · | · | |
| EV / Gelir (TTM) | 11.1 | · | · | · | |
| EV / FCF (TTM) | -13.2 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | URGN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 90.8% | · | 64.8% | En üst düzey | |
| Faaliyet Kâr Marjı (TTM) | -35.3% | · | 7.3% | Zayıf | |
| FAVÖK Marjı (TTM) | -35.2% | · | 7.9% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | -52.0% | · | 0.48% | Zayıf | |
| Net Kâr Marjı (TTM) | -51.7% | · | -4.3% | Zayıf | |
| ROA | -63.1% | · | -28.9% | Zayıf | |
| ROE | 154.4% | · | 26.2% | En üst düzey | |
| ROIC | -746.5% | · | -39.8% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | URGN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | -1.4 | · | · | · | |
| Cari Oran (MRQ) | 3.8 | · | 5.3 | Düşük likidite | |
| Cari Oran (MRQ) | 3.2 | · | 3.8 | Düşük likidite | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | -1.4 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | URGN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 21.4%5Y ort. ≈80.1% | ≈80.1% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 19.5%5Y ort. ≈44.8% | ≈44.8% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 56.2% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | URGN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.5 | · | 0.5 | Zayıf | |
| Inventory Turnover (Stok Devir Hızı) | 1.0 | · | · | · | |
| Receivables Turnover (Alacak Devir Hızı) | 4.1 | · | · | · | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$366.0K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-5.1%
Sonraki Rapor
Kas 04, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $-0.28 | $-0.29 | 4.4% |
| 31 Mart 2026 | May 11, 2026 | $-0.47 | $-0.49 | 4.5% |
| 31 Aralık 2025 | $-0.54 | $-0.51 | -5.4% | |
| 30 Eylül 2025 | $-0.69 | $-0.71 | 2.3% | |
| 30 Haziran 2025 | $-1.05 | $-0.85 | -23.5% | |
| 31 Mart 2025 | $-0.92 | $-0.82 | -12.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $110M | $90M | $83M | $64M | $48M | $12M | $18.0K | $1M | $8M | |
| Cost of Revenue | $12M | $9M | $9M | $8M | $5M | $1M | · | $2M | $600.0K | |
| Gross Profit | $97M | $82M | $73M | $57M | $43M | $11M | $18.0K | $-675.0K | $8M | |
| R&D Expense | $67M | $57M | $46M | $53M | $48M | $47M | $49M | $37M | $19M | |
| SG&A Expense | $155M | $121M | $93M | $83M | $88M | $90M | $60M | $40M | $9M | |
| Operating Expenses | · | · | · | · | · | · | $109M | $77M | $28M | |
| Operating Income | $-125M | $-97M | $-66M | $-79M | $-92M | $-127M | $-109M | $-77M | $-20M | |
| Interest Income | $6M | $9M | $3M | $938.0K | $365.0K | $2M | $5M | · | · | |
| Other Non-op | $-670.0K | $-229.0K | $838.0K | $72.0K | $-153.0K | · | $-284.0K | $-124.0K | $12.0K | |
| Pretax Income | $-153M | $-124M | $-98M | $-108M | $-109M | $-125M | $-105M | $-76M | $-20M | |
| Income Tax | $78.0K | $3M | $4M | $2M | $1M | $3M | · | $125.0K | $19.0K | |
| Net Income | $-153M | $-127M | $-102M | $-110M | $-111M | $-128M | $-105M | $-76M | $-20M | |
| EPS (Basic) | $-3.19 | $-2.96 | $-3.55 | $-4.81 | $-4.96 | · | · | · | · | |
| Shares (Basic) | 48,116,098 | 42,876,737 | 28,834,303 | 22,806,812 | 22,347,481 | · | · | · | · | |
| EBITDA | $-125M | · | · | · | $-91M | $-126M | $-109M | $-77M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $172M | $95M | $55M | $44M | $53M | $50M | $101M | $37M | |
| Short-term Investments | $49M | $111M | $56M | · | · | · | · | · | $36M | |
| Receivables | $33M | $20M | $15M | $13M | $12M | $7M | · | · | · | |
| Inventory | $16M | $9M | $6M | $4M | $5M | $2M | · | · | $316.0K | |
| Prepaid Expense | $15M | $9M | $10M | $11M | $7M | $3M | $1M | $672.0K | $958.0K | |
| Current Assets | $186M | $276M | $169M | $129M | $114M | $116M | $149M | $102M | $74M | |
| PP&E (Net) | $637.0K | $655.0K | $689.0K | $1M | $2M | $2M | $977.0K | $948.0K | $805.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $1M | |
| Accum. Depreciation | $5M | $4M | $4M | $3M | $2M | $1M | $998.0K | $747.0K | $577.0K | |
| Other Non-current Assets | $5M | $589.0K | $2M | $3M | $1M | $66.0K | $264.0K | $317.0K | $244.0K | |
| Total Assets | $200M | $286M | $178M | $136M | $120M | $122M | $202M | $104M | $76M | |
| Accounts Payable | $12M | $11M | $7M | $6M | $6M | $3M | $5M | $4M | $3M | |
| Current Liabilities | $46M | $46M | $31M | $24M | $22M | $21M | $19M | $13M | $7M | |
| Capital Leases | $3M | $58.0K | $0 | $2M | $398.0K | $1M | $3M | · | · | |
| Total Liabilities | $306M | $295M | $244M | $225M | $111M | $26M | $22M | $13M | $7M | |
| Long-term Debt | $125M | · | · | · | · | · | · | · | · | |
| Total Debt | $122M | · | · | · | · | · | · | · | · | |
| Common Stock | $133.0K | $115.0K | $89.0K | $63.0K | $61.0K | $60.0K | $57.0K | $44.0K | $37.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | $213M | $116M | |
| Retained Earnings | $-960M | $-806M | $-679M | $-577M | $-467M | $-357M | $-228M | $-123M | $-47M | |
| AOCI | $19.0K | $56.0K | $12.0K | $-107.0K | $-25.0K | $271.0K | $276.0K | · | · | |
| Stockholders' Equity | $-105M | $-9M | $-65M | $-89M | $8M | $96M | $180M | $90M | $69M | |
| Liabilities + Equity | $200M | $286M | $178M | $136M | $120M | $122M | $202M | $104M | $76M | |
| Shares Outstanding | 48,350,272 | 42,231,746 | 32,490,119 | 23,129,953 | 22,462,995 | 22,167,791 | 21,026,184 | 16,214,883 | 13,751,390 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $307.0K | $329.0K | $802.0K | $924.0K | $831.0K | $416.0K | $300.0K | $400.0K | $200.0K | |
| Stock-based Comp | $12M | $13M | $9M | $11M | $23M | $28M | $30M | $31M | $6M | |
| Other Non-cash | $-21M | · | · | · | $2M | $-6M | $4M | $7M | · | |
| Operating Cash Flow | $-162M | $-97M | $-76M | $-88M | $-85M | $-106M | $-71M | $-37M | $-10M | |
| CapEx | $289.0K | $295.0K | $194.0K | $254.0K | $752.0K | $1M | $325.0K | $560.0K | $271.0K | |
| Investing Cash Flow | $62M | $-21M | $-953.0K | $1M | $4M | $93M | $-146M | $35M | $-36M | |
| Debt Issued | $0 | $24M | $0 | $96M | $0 | · | · | · | · | |
| Net Debt Issued | $0 | · | · | · | · | · | · | · | · | |
| Stock Issued | $40M | $151M | $67M | $0 | $0 | $16M | $162M | $64M | $61M | |
| Net Stock Activity | $40M | · | · | · | $0 | $16M | $162M | $64M | · | |
| Financing Cash Flow | $40M | $195M | $117M | $97M | $72M | $17M | $165M | $66M | $62M | |
| Net Change in Cash | $-61M | $77M | $40M | $11M | $-9M | $4M | $-51M | $64M | $16M | |
| Taxes Paid | $3M | $2M | · | · | · | · | · | · | · | |
| Free Cash Flow | $-163M | · | · | · | $-86M | $-107M | $-71M | $-38M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 88.7% | · | · | · | 89.3% | 91.5% | 100.0% | -59.8% | · | |
| Operating Margin | -113.7% | · | · | · | -192.1% | -1074.2% | -608211.1% | -6842.2% | · | |
| Net Margin | -139.8% | · | · | · | -230.7% | -1088.9% | -584144.4% | -6707.2% | · | |
| Pretax Margin | -139.7% | · | · | · | -227.7% | -1060.3% | -584144.4% | -6696.1% | · | |
| EBITDA Margin | -113.5% | · | · | · | -190.4% | -1070.8% | -606544.4% | -6806.7% | · | |
| ROA | -63.1% | · | · | · | -91.7% | -79.2% | -68.7% | -84.5% | · | |
| ROE | 154.4% | · | · | · | -554.8% | -118.5% | -53.8% | -78.1% | · | |
| ROIC | -746.5% | · | · | · | -1111.6% | -135.1% | · | -85.8% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | · | · | · | 5.1 | 5.4 | 7.6 | 7.6 | · | |
| Quick Ratio | 4.2 | · | · | · | 2.5 | 2.8 | 2.6 | 7.5 | · | |
| Debt / Equity | -1.2 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | -1.2 | · | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | · | · | 0.4 | 0.1 | 0.0 | 0.0 | · | |
| Inventory Turnover | 1.0 | · | · | · | 1.5 | 0.9 | · | · | · | |
| Receivables Turnover | 4.1 | · | · | · | 5.1 | 3.3 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.18 | · | · | · | $0.37 | $4.35 | $8.58 | $5.56 | · | |
| Cash / Share | $2.29 | · | · | · | $1.97 | $2.38 | $2.36 | $6.25 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.4% | 9.3% | 28.5% | 34.0% | 307.2% | · | · | · | · | |
| Revenue CAGR 3Y | 19.5% | 23.5% | 91.4% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 56.2% | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $110M | $90M | $83M | $64M | $48M | $12M | $18.0K | $1M | · | |
| Net Income TTM | $-153M | $-127M | $-102M | $-110M | $-111M | $-128M | $-105M | $-76M | · | |
| Market Cap | $1.13B | · | · | · | $214M | $399M | $702M | $698M | · | |
| Enterprise Value | $1.09B | · | · | · | · | · | · | · | · | |
| P/S | 10.3 | · | · | · | 4.4 | 33.9 | 38980.2 | 619.0 | · | |
| P/B | -10.7 | · | · | · | 25.4 | 4.1 | 3.9 | 7.7 | · | |
| P / Tangible Book | · | · | · | · | 25.4 | 4.1 | · | · | · | |
| P / Cash Flow | -7.0 | · | · | · | -2.5 | -3.8 | -9.9 | -18.7 | · | |
| P / FCF | -7.0 | · | · | · | -2.5 | -3.7 | -9.8 | -18.4 | · | |
| EV / EBITDA | -8.8 | · | · | · | · | · | · | · | · | |
| EV / FCF | -6.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 10.0 | · | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $51M | $38M | $27M | $24M | $20M | $25M | $25M | $22M | $19M | $24M | $21M | $21M | $17M | $18M | $16M | |
| Cost of Revenue | $7M | $4M | $3M | $3M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Gross Profit | $66M | $47M | $35M | $24M | $21M | $18M | $22M | $23M | $20M | $17M | $21M | $18M | $19M | $15M | $16M | $14M | |
| R&D Expense | $17M | $16M | $14M | $14M | $19M | $20M | $15M | $11M | $15M | $15M | $11M | $10M | $12M | $12M | $14M | $13M | |
| SG&A Expense | $48M | $51M | $39M | $38M | $43M | $35M | $35M | $29M | $30M | $27M | $25M | $22M | $22M | $24M | $22M | $19M | |
| Operating Income | $111.0K | $-20M | $-19M | $-27M | $-41M | $-37M | $-28M | $-18M | $-26M | $-26M | $-15M | $-14M | $-15M | $-22M | $-20M | $-18M | |
| Interest Income | $946.0K | $931.0K | $908.0K | $1M | $2M | $2M | $3M | $3M | $2M | $2M | $726.0K | $835.0K | $435.0K | $645.0K | $469.0K | $441.0K | |
| Other Non-op | $-347.0K | $-323.0K | $-5.0K | $-197.0K | $-378.0K | $-90.0K | $-62.0K | $-158.0K | $174.0K | $-183.0K | $812.0K | $71.0K | $-30.0K | $-15.0K | $-63.0K | $37.0K | |
| Pretax Income | $-9M | $-28M | $-27M | $-34M | $-49M | $-43M | $-35M | $-24M | $-33M | $-32M | $-22M | $-22M | $-24M | $-30M | $-28M | $-25M | |
| Income Tax | $6M | $-5M | $-275.0K | $-1M | $1M | $392.0K | $3M | $91.0K | $38.0K | $54.0K | $4M | $-9.0K | $54.0K | $21.0K | $689.0K | $709.0K | |
| Net Income | $-14M | $-24M | $-26M | $-33M | $-50M | $-44M | $-38M | $-24M | $-33M | $-32M | $-26M | $-22M | $-24M | $-30M | $-29M | $-26M | |
| EPS (Basic) | $-0.28 | $-0.47 | $-0.53 | $-0.69 | $-1.05 | $-0.92 | $-0.76 | $-0.51 | $-0.82 | $-0.87 | $-0.72 | $-0.68 | $-1.03 | $-1.30 | $-1.25 | $-1.13 | |
| Shares (Basic) | 50,380,112 | 50,182,758 | · | 48,057,386 | 47,739,816 | 47,422,119 | 47,030,820 | 46,779,637 | 40,501,315 | 37,059,186 | 36,153,634 | 32,298,182 | 23,462,016 | 23,279,951 | · | 22,798,263 | |
| EBITDA | $211.0K | $-20M | · | $-27M | $-41M | $-37M | · | $-17M | $-26M | $-26M | · | $-13M | $-15M | $-22M | · | $-18M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $79M | $110M | $111M | $90M | $93M | $104M | $172M | $125M | $220M | $131M | $95M | $119M | $20M | $37M | $55M | $29M | |
| Short-term Investments | $30M | $40M | $49M | $64M | $83M | $112M | $111M | $154M | $52M | $52M | $56M | $55M | $36M | $39M | · | · | |
| Receivables | $89M | $55M | $33M | $20M | $20M | $20M | $20M | $23M | $17M | $14M | $15M | $13M | $16M | $12M | $13M | $9M | |
| Inventory | $25M | $21M | $16M | $8M | $7M | $8M | $9M | $8M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $5M | |
| Prepaid Expense | $13M | $20M | $15M | $12M | $12M | $13M | $9M | $14M | $12M | $10M | $10M | $16M | $13M | $12M | $11M | $11M | |
| Current Assets | $235M | $237M | $186M | $169M | $197M | $237M | $276M | $295M | $279M | $197M | $169M | $182M | $81M | $96M | $129M | $122M | |
| PP&E (Net) | $597.0K | $616.0K | $637.0K | $695.0K | $688.0K | $627.0K | $655.0K | $608.0K | $580.0K | $566.0K | $689.0K | $823.0K | $910.0K | $1M | $1M | $2M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | $9M | $7M | $5M | $7M | $801.0K | $371.0K | $589.0K | $370.0K | $673.0K | $1M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Total Assets | $253M | $254M | $200M | $185M | $209M | $248M | $286M | $302M | $282M | $201M | $178M | $194M | $95M | $113M | $136M | $128M | |
| Accounts Payable | $15M | $17M | $12M | $10M | $14M | $15M | $11M | $6M | $8M | $6M | $7M | $4M | $5M | $7M | $6M | $3M | |
| Current Liabilities | $62M | $51M | $46M | $42M | $48M | $42M | $46M | $33M | $34M | $26M | $31M | $26M | $27M | $25M | $24M | $19M | |
| Capital Leases | $2M | $2M | $3M | $3M | $552.0K | $3.0K | $58.0K | $212.0K | $425.0K | $637.0K | $0 | $1M | $1M | $1M | $2M | $2M | |
| Total Liabilities | $385M | $378M | $306M | $300M | $302M | $294M | $295M | $276M | $252M | $241M | $244M | $236M | $234M | $230M | $225M | $192M | |
| Long-term Debt | $200M | $200M | $125M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $189M | $190M | · | $122M | $123M | $122M | · | $122M | $98M | $98M | · | $99M | $98M | $98M | · | $72M | |
| Common Stock | $135.0K | $134.0K | $133.0K | $128.0K | $126.0K | $126.0K | $115.0K | $115.0K | $112.0K | $99.0K | $89.0K | $84.0K | $64.0K | $64.0K | $63.0K | $63.0K | |
| Retained Earnings | $-998M | $-983M | $-960M | $-933M | $-900M | $-850M | $-806M | $-769M | $-745M | $-712M | $-679M | $-653M | $-631M | $-607M | $-577M | $-548M | |
| AOCI | $-2.0K | $8.0K | $19.0K | $23.0K | $6.0K | $14.0K | $56.0K | $236.0K | $-31.0K | $-37.0K | $12.0K | $-134.0K | $-154.0K | $-45.0K | $-107.0K | $-155.0K | |
| Stockholders' Equity | $-132M | $-124M | $-105M | $-115M | $-93M | $-46M | $-9M | $26M | $30M | $-40M | $-65M | $-42M | $-138M | $-117M | $-89M | $-63M | |
| Liabilities + Equity | $253M | $254M | $200M | $185M | $209M | $248M | $286M | $302M | $282M | $201M | $178M | $194M | $95M | $113M | $136M | $128M | |
| Shares Outstanding | 48,869,530 | 48,708,280 | 48,350,272 | 46,781,211 | 46,199,134 | 46,101,785 | 42,231,746 | 42,190,815 | 41,169,954 | 36,127,687 | 32,490,119 | 30,854,778 | 23,498,617 | 23,440,521 | 23,129,953 | 23,011,324 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $100.0K | $75.0K | $35.0K | $100.0K | $100.0K | $72.0K | $6.0K | $100.0K | $100.0K | $123.0K | $185.0K | $200.0K | $200.0K | $217.0K | $309.0K | $200.0K | |
| Stock-based Comp | $5M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $-26M | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-33M | $-45M | $-38M | $-42M | $-40M | $-42M | $-14M | $-28M | $-24M | $-32M | $-13M | $-17M | $-20M | $-26M | $-22M | $-18M | |
| CapEx | $60.0K | $54.0K | $17.0K | $87.0K | $141.0K | $44.0K | $115.0K | $96.0K | $84.0K | $0 | $56.0K | $100.0K | $15.0K | $23.0K | $13.0K | $153.0K | |
| Investing Cash Flow | $2M | $-21M | $28M | $31M | $28M | $-26M | $61M | $-107M | $12M | $14M | $-11M | $401.0K | $4M | $6M | $23M | $-35M | |
| Debt Issued | $0 | $65M | $0 | $0 | $0 | $0 | $0 | · | · | · | $0 | $0 | $0 | $0 | $25M | $0 | |
| Net Debt Issued | · | $65M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | $0 | $32M | $8M | $-4.0K | $4.0K | $0 | $15M | $82M | $55M | $0 | $67M | $0 | $0 | $0 | · | |
| Net Stock Activity | · | $0 | · | · | · | $4.0K | · | · | · | $55M | · | · | · | · | · | · | |
| Financing Cash Flow | $500.0K | $65M | $31M | $8M | $296.0K | $34.0K | $71.0K | $40M | $100M | $55M | $40.0K | $116M | $143.0K | $671.0K | $25M | $1M | |
| Net Change in Cash | $-31M | $-800.0K | $21M | $-3M | $-11M | $-68M | $47M | $-95M | $89M | $36M | $-24M | $99M | $-16M | $-19M | $27M | $-52M | |
| Free Cash Flow | · | $-45M | · | · | · | $-42M | · | · | · | $-32M | · | · | · | $-26M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 90.9% | 91.9% | · | 88.1% | 85.3% | 88.5% | · | 90.3% | 89.8% | 90.8% | · | 88.6% | 88.4% | 86.8% | · | 87.5% | |
| Operating Margin | 0.15% | -39.8% | · | -99.7% | -171.2% | -182.3% | · | -69.6% | -118.3% | -137.1% | · | -64.7% | -72.8% | -128.2% | · | -112.4% | |
| Net Margin | -19.8% | -46.3% | · | -121.3% | -206.2% | -216.5% | · | -93.9% | -152.9% | -171.9% | · | -104.9% | -114.2% | -175.7% | · | -160.5% | |
| Pretax Margin | -12.0% | -55.6% | · | -125.2% | -202.0% | -214.5% | · | -93.6% | -152.7% | -171.6% | · | -105.0% | -113.9% | -175.6% | · | -156.1% | |
| EBITDA Margin | 0.29% | -39.6% | · | -99.3% | -170.8% | -181.9% | · | -69.2% | -117.8% | -136.4% | · | -63.8% | -71.8% | -127.0% | · | -111.1% | |
| ROA | -6.2% | -9.4% | · | -13.7% | -20.4% | -19.6% | · | -9.6% | -17.7% | -20.6% | · | -13.6% | -20.0% | -21.7% | · | -19.6% | |
| ROE | 12.7% | 27.6% | · | 74.2% | 158.4% | 101.3% | · | 287.3% | 61.8% | 41.2% | · | 41.6% | 26.9% | 45.2% | · | 162.7% | |
| ROIC | 0.32% | -25.8% | · | -396.1% | -145.2% | -49.2% | · | -12.0% | -20.2% | -44.9% | · | -23.9% | 38.4% | 118.5% | · | -216.7% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.7 | · | 4.0 | 4.1 | 5.6 | · | 9.0 | 8.2 | 7.5 | · | 7.1 | 3.0 | 3.8 | · | 6.4 | |
| Quick Ratio | 3.2 | 4.1 | · | 4.1 | 4.1 | 5.6 | · | 9.2 | 8.5 | 7.5 | · | 7.3 | 2.7 | 3.5 | · | 2.0 | |
| Debt / Equity | -1.4 | -1.5 | · | -1.1 | -1.3 | -2.6 | · | 4.8 | 3.2 | -2.4 | · | -2.3 | -0.7 | -0.8 | · | -1.1 | |
| LT Debt / Equity | -1.4 | -1.5 | · | -1.1 | -1.3 | -2.6 | · | 4.8 | 3.2 | -2.4 | · | -2.3 | -0.7 | -0.8 | · | -1.1 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.3 | · | 0.5 | 0.5 | 0.4 | · | 0.5 | |
| Receivables Turnover | 1.3 | 1.4 | · | 1.3 | 1.3 | 1.2 | · | 1.4 | 1.3 | 1.4 | · | 1.9 | 1.6 | 1.6 | · | 1.9 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.71 | $-2.55 | · | $-2.47 | $-2.02 | $-1.01 | · | $0.60 | $0.74 | $-1.11 | · | $-1.36 | $-5.89 | $-4.97 | · | $-2.75 | |
| Cash / Share | $1.62 | $2.26 | · | $1.92 | $2.01 | $2.26 | · | $2.96 | $5.34 | $3.64 | · | $3.87 | $0.86 | $1.56 | · | $1.25 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $189M | $140M | · | $97M | $94M | $92M | · | $89M | $85M | $84M | · | $77M | $73M | $68M | · | $62M | |
| Net Income TTM | $-98M | $-133M | · | $-165M | $-155M | $-138M | · | $-115M | $-114M | $-104M | · | $-105M | $-109M | $-112M | · | $-109M | |
| Market Cap | $1.80B | $876M | · | $933M | $633M | $510M | · | $536M | $691M | $542M | · | $432M | $243M | $217M | · | $191M | |
| Enterprise Value | $1.88B | $916M | · | $902M | $579M | $416M | · | $379M | $516M | $456M | · | $356M | $285M | $239M | · | $235M | |
| P/S | 9.5 | 6.2 | · | 9.7 | 6.7 | 5.5 | · | 6.0 | 8.1 | 6.4 | · | 5.6 | 3.4 | 3.2 | · | 3.1 | |
| P/B | -13.6 | -7.0 | · | -8.1 | -6.8 | -11.0 | · | 21.0 | 22.8 | -13.5 | · | -10.3 | -1.8 | -1.9 | · | -3.0 | |
| P / Tangible Book | · | · | · | · | · | · | · | 21.0 | 22.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -19.3 | · | · | · | -12.1 | · | · | · | -17.1 | · | · | · | -8.4 | · | · | |
| EV / Revenue | 9.9 | 6.5 | · | 9.3 | 6.1 | 4.5 | · | 4.2 | 6.1 | 5.4 | · | 4.6 | 3.9 | 3.5 | · | 3.8 |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $110M | $90M | $83M | $64M | $48M |
| Brüt Kâr Marjı % | 88.7% | · | · | · | 89.3% |
| Faaliyet Kâr Marjı % | -113.7% | · | · | · | -192.1% |
| Net Gelir | $-153M | $-127M | $-102M | $-110M | $-111M |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -1.2 | · | · | · | · |
| Cari Oran | 4.0 | · | · | · | 5.1 |
| Cari Oran | 4.2 | · | · | · | 2.5 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-163M | · | · | · | $-86M |
Kurumsal Sahipler (13F) 203 dosya · $1.5B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
203
Tutulan Değer
$1.5B
Yeni pozisyonlar
41
Çıkan pozisyonlar
19
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 41 (+5 önceki Ç'ye göre) | 19 (-7 önceki Ç'ye göre) | 61 (+10 önceki Ç'ye göre) | 56 (+7 önceki Ç'ye göre) | -4.1M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RTW INVESTMENTS, LP | $167.215.336 | 4.543.895 | 11,19% | Hisse senetleri |
| BlackRock, Inc. | $117.813.765 | 3.201.461 | 7,88% | Hisse senetleri |
| MORGAN STANLEY | $94.810.189 | 2.576.363 | 6,34% | Hisse senetleri |
| Kynam Capital Management, LP | $89.578.818 | 2.434.207 | 5,99% | Hisse senetleri |
| Jefferies Financial Group Inc. | $80.947.194 | 2.199.652 | 5,42% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $62.034.564 | 1.685.719 | 4,15% | Hisse senetleri |
| ACORN CAPITAL ADVISORS, LLC | $61.581.856 | 1.673.420 | 4,12% | Hisse senetleri |
| Point72 Asset Management, L.P. | $56.140.203 | 1.525.549 | 3,76% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $55.514.521 | 1.508.547 | 3,71% | Hisse senetleri |
| Opaleye Management Inc. | $52.991.853 | 1.439.996 | 3,55% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $47.912.827 | 1.301.979 | 3,21% | Hisse senetleri |
| MENORA MIVTACHIM HOLDINGS LTD. | $42.413.141 | 1.152.531 | 2,84% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $42.166.139 | 1.145.819 | 2,82% | Hisse senetleri |
| STATE STREET CORP | $36.913.013 | 1.003.071 | 2,47% | Hisse senetleri |
| MPM BIOIMPACT LLC | $34.349.672 | 933.415 | 2,30% | Hisse senetleri |
| Soleus Capital Management, L.P. | $30.537.008 | 829.810 | 2,04% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $30.169.892 | 819.834 | 2,02% | Hisse senetleri |
| Migdal Insurance & Financial Holdings Ltd. | $28.369.451 | 770.909 | 1,90% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $24.883.682 | 676.187 | 1,67% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $22.461.394 | 610.364 | 1,50% | Hisse senetleri |
| Woodline Partners LP | $18.426.717 | 500.726 | 1,23% | Hisse senetleri |
| Boxer Capital Management, LLC | $18.400.000 | 500.000 | 1,23% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $17.505.834 | 475.702 | 1,17% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $16.801.334 | 456.558 | 1,12% | Hisse senetleri |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $14.244.323 | 387.074 | 0,95% | Hisse senetleri |
| NORTHERN TRUST CORP | $11.208.175 | 304.570 | 0,75% | Hisse senetleri |
| RICE HALL JAMES & ASSOCIATES, LLC | $11.063.920 | 300.650 | 0,74% | Hisse senetleri |
| VANGUARD GROUP INC | $10.298.969 | 439.751 | 0,69% | Hisse senetleri |
| ADAR1 Capital Management, LLC | $9.288.136 | 252.395 | 0,62% | Hisse senetleri |
| J. Goldman & Co LP | $7.830.120 | 212.775 | 0,52% | Hisse senetleri |
| Privium Fund Management B.V. | $7.728.000 | 210.000 | 0,52% | Hisse senetleri |
| FMR LLC | $7.253.198 | 197.098 | 0,49% | Hisse senetleri |
| SUPERSTRING CAPITAL MANAGEMENT LP | $7.040.318 | 191.313 | 0,47% | Hisse senetleri |
| Parkman Healthcare Partners LLC | $6.405.555 | 174.064 | 0,43% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.531.040 | 150.300 | 0,37% | Alım opsiyonu |
| AQR CAPITAL MANAGEMENT LLC | $5.491.591 | 149.228 | 0,37% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $5.481.838 | 148.963 | 0,37% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.724.016 | 128.370 | 0,32% | Hisse senetleri |
| UBS Group AG | $4.469.764 | 121.461 | 0,30% | Hisse senetleri |
| Elmind Capital, LP | $4.416.000 | 120.000 | 0,30% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $4.245.322 | 115.362 | 0,28% | Hisse senetleri |
| Bank of New York Mellon Corp | $4.159.416 | 113.028 | 0,28% | Hisse senetleri |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $4.089.989 | 111.141 | 0,27% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.084.800 | 111.000 | 0,27% | Satım opsiyonu |
| Aisling Capital Management LP | $3.974.400 | 108.000 | 0,27% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $3.926.266 | 106.692 | 0,26% | Hisse senetleri |
| ARK Investment Management LLC | $3.735.494 | 101.508 | 0,25% | Hisse senetleri |
| Russell Investments Group, Ltd. | $3.495.260 | 94.979 | 0,23% | Hisse senetleri |
| Nuveen, LLC | $3.389.354 | 92.102 | 0,23% | Hisse senetleri |
| OAK RIDGE INVESTMENTS LLC | $3.260.149 | 88.591 | 0,22% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Monograph Capital Partners I, L.P., Monograph Capital Partners I GenPar, LP, Monograph Capital Holdings Advisors, LLC, Fred Cohen, Charles Conn ×2 başvurular | 09 Haziran 2025 | 1,90% | Değişiklik | · | SEC |
| Pontifax Management III G.P. (2011) Ltd., Pontifax Management Fund III L.P., Pontifax (Cayman) III, L.P., Pontifax (Israel) III, L.P. ×2 başvurular | 18 Kasım 2024 | · | İlk başvuru | · | SEC |
| Arkin Communications Ltd., Moshe Arkin ×5 başvurular | 22 Şubat 2024 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 18 içeriden öğrenenler · 8 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Elizabeth A. Barrett | Chief Executive Officer | 31 Ocak 2026 A | 326.691 | 0 | 0 | $0 |
| Chris Degnan | Chief Financial Officer | 31 Ocak 2026 A | 2.280 | 0 | 1 | $-37.121 |
| Dong Kim | Chief Financial Officer | 09 Eylül 2024 M | 37.753 | 0 | 0 | $0 |
| Molly Henderson | Chief Financial Officer | 31 Ocak 2022 A | 5.248 | 0 | 0 | $0 |
| Peter P. Pfreundschuh | Chief Financial Officer | 15 Ekim 2020 M | 10.405 | 0 | 0 | $0 |
| Stephen Mullennix | Chief Operating Officer | 26 Nisan 2020 M | 10.084 | 0 | 0 | $0 |
| Jason Drew Smith | General Counsel | 07 Eylül 2026 M | 53.141 | 0 | 4 | $-211.880 |
| Mark Schoenberg | Chief Medical Officer | 07 Eylül 2026 M | 59.882 | 0 | 10 | $-4.480.071 |
| James A. Robinson Jr. | Yönetim kurulu üyesi | 26 Ağustos 2026 M | 8.000 | 0 | 0 | $0 |
| Daniel George Wildman | Yönetim kurulu üyesi | 22 Haziran 2026 A | 2.000 | 0 | 0 | $0 |
| Leana Wen | Yönetim kurulu üyesi | 22 Haziran 2026 A | 2.000 | 0 | 0 | $0 |
| Stuart Holden | Yönetim kurulu üyesi | 22 Haziran 2026 A | 2.000 | 0 | 0 | $0 |
| Arie Belldegrun | Yönetim kurulu üyesi | 22 Haziran 2026 A | 408.693 | 0 | 0 | $0 |
| Cynthia M Butitta | Yönetim kurulu üyesi | 22 Haziran 2026 A | 2.000 | 0 | 0 | $0 |
| Fred Cohen | Yönetim kurulu üyesi | 06 Ağustos 2024 A | 69.339 | 0 | 0 | $0 |
| Ran Nussbaum | Yönetim kurulu üyesi | 06 Haziran 2022 M | 1.434.958 | 0 | 0 | $0 |
| Shawn Tomasello | Yönetim kurulu üyesi | 07 Haziran 2021 A | · | 0 | 0 | $0 |
| Kathryn E Falberg | Yönetim kurulu üyesi | 07 Haziran 2021 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 16 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IWC · iShares Trust | 0,43% | 144.680 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3.462 SH | 01 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,12% | 292.761 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,10% | 346.062 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,09% | 46.360 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 39.426 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,06% | 1.093.348 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,05% | 20.398 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 245.185 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,02% | 117.009 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,02% | 2.420 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.082 SH | 19 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 15.388 SH | 11 Eylül 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.496 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 55.945 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 31.171 SH | 11 Eylül 2026 | Günlük |
URGN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 14 analist
AL
Medyan hedef
$59.00
+42,5%
6 42,9%
Güçlü Al
6 42,9%
Al
2 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
8 analist · 2026-09-29Ortalama hedef $60.00 +44,9%
← Tüm hedeflerin altında
Mevcut fiyat $41.40
Düşük$48.00
Ortalama$60.00
Yüksek$75.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026